FDA authorizes antibody cocktail as preventative COVID treatment – One America News Network
WHITE OAK, MD – JULY 20: A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. (Sarah Silbiger/Getty Images)
OAN NewsroomUPDATED 1:54 PM PT – Wednesday, August 4, 2021
The U.S. Food and Drug Administration (FDA) has authorized a monoclonal antibody cocktail as a treatment for immunocompromised people who are at risk of COVID exposure. Reports on Tuesday detailed the authorization made last week, which said those with compromised immune systems could receive the optional treatment.
“It’s good to know that for people who do not respond well to vaccines, including those who do not make antibodies, we can now help protect them against getting infected with SARS-CoV-2 by giving them antibodies following expo...